DFNB1A
Clinical trials for DFNB1A explained in plain language.
Never miss a new study
Get alerted when new DFNB1A trials appear
Sign up with your email to follow new studies for DFNB1A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-time gene therapy aims to restore hearing in kids with genetic deafness
Disease control Recruiting nowThis early-stage trial tests a new gene therapy called SKY-GJB2 for children aged 9 months to 7 years with hearing loss caused by changes in the GJB2 gene. The therapy is given as a single injection into the inner ear using a special delivery device. The study will enroll 10 chil…
Matched conditions: DFNB1A
Phase: PHASE1, PHASE2 • Sponsor: Skylark Bio Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Scientists track hearing loss in kids to unlock future treatments
Knowledge-focused Recruiting nowThis study follows 180 children up to age 16 who have hearing loss caused by mutations in the GJB2 or OTOF genes. Researchers will regularly measure their hearing using standard tests and questionnaires to see how it changes over time. The goal is to better understand the natural…
Matched conditions: DFNB1A
Sponsor: Sensorion • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC